Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma.
Sarkozy C, Callanan M, Thieblemont C, Obéric L, Burroni B, Bouabdallah K, Damaj G, Tessoulin B, Ribrag V, Houot R, Morschhauser F, Griolet S, Joubert C, Cacheux V, Delwail V, Safar V, Gressin R, Cheminant M, Delfau-Larue MH, Hermine O, Macintyre E, Le Gouill S.
Sarkozy C, et al. Among authors: callanan m.
Blood. 2024 Jul 18;144(3):262-271. doi: 10.1182/blood.2024023944.
Blood. 2024.
PMID: 38669626
Free article.
Clinical Trial.